Ingredient record · Glucose solution used in drips
Dextrose: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
1 entry containing Dextrose is on India's banned-drugs list, and 1 is banned today. 32 batches of medicines containing Dextrose failed a government lab test between February 2019 and July 2026, from 26 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
1
Banned combinations in force
0
Other listed orders (stayed, restricted, quashed)
32
Batches failed a lab test
Jul 2026
Latest lab alert
On the banned-drugs list
Dextrose on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Patent and Proprietary Oral Rehydration Salts other than Those Conforming to the Following Parameters: (a) Patent and Proprietary Oral Rehydration Salts on Reconstitution to One Litre Shall Contain: Sodium, 50 to 90 Milliosmoles Total Osmolarity, 240-290 Milliosmoles Dextrose: Sodium Molar Ratio, not less than 1:1 and not More than 3:1 (B) Patent and Proprietary Cereal Based Oral Rehydration Salts on Reconstitution to One Litre Shall Contain: Sodium, 50 to 90 Milliosmoles Total Osmolarity, not More than 290 Milliosmoles Precooked Rice, Equivalent to not less than 50gms and not More than 80gms as Total Replacement of Dextrose (C) Patent and Proprietary Oral Rehydration Salts (ORS) May Contain Amino Acids in Addition to Oral Rehydration Salts Conforming to the Parameters Specified Above and Labelled with the Indication for "Adult Chloretic Diarrhea Only" (D) Patent and Proprietary Oral Rehydration Salts (ORS) Shall not Contain Mono or Polysaccharides or Saccharin Sweetening AgentFixed-dose combination · other | Banned | GSR 57(E) | 7 February 1995 | Classic bans | In force per CDSCO consumer list (1983-2017) |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Bupivacaine Hydrochloride in Dextrose | 11 | 9 | Jan 2026 |
| Sodium Chloride Dextrose | 4 | 3 | Apr 2026 |
| Multiple Electrolytes Dextrose Type I | 3 | 2 | Sep 2025 |
| W/v Sodium Chloride Dextrose | 2 | 2 | Jun 2025 |
| Peritoneal Dialysis W/v Dextrose | 2 | 2 | Jan 2023 |
| Amino Acids Electrolytes Dextrose Intravenous Fat Emulsion Medium Long Chain Triglycerides in A Triple Chamber Bag | 1 | 1 | Jul 2026 |
| Dextrose W/v | 1 | 1 | Jun 2025 |
| Multiple Electrolytes Dextrose Type | 1 | 1 | May 2025 |
| Bupivaaine Hydrochloride in Dextrose | 1 | 1 | Feb 2025 |
| Dextrose Ascorbic Acid Zinc | 1 | 1 | Jul 2024 |
| Bupivacaine Hydrochloride in Dextrose Amp | 1 | 1 | Apr 2024 |
| Multielectrolyte W/v Dextrose Intalyte | 1 | 1 | Jul 2023 |
| Bupivacaine Heavy | 1 | 1 | May 2023 |
| Bupicain Heavy | 1 | 1 | Nov 2022 |
| Sodium Chloride Dextrose D Ns | 1 | 1 | Feb 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Amino Acids (10%w/v) Injection with Electrolytes, Dextrose Injection IP (15%w/v) and Intravenous Fat Emulsion with Medium & Long Chain Triglycerides (20% w/v) in a Triple Chamber Bag | 5D250116Mfg 2025-04 · Exp 2027-03 | Acculife Healthcare Pvt. LtdGujarat | The sample does not conform to claim with respect to Assay of L-Cysteine Hydrochloride Monohydrate, Sterility and Bacterial Endotoxin test of Infusion set.Assay | CDL, KolkataCDSCO lab | Jul 2026 |
| Sodium Chloride (0.9% w/v) & Dextrose (5%w/v) Injection IP | PT25DNS2148CMfg 2025-11 · Exp 2028-10 | Promea Therapeutics Private LimitedTelangana | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab | Apr 2026 |
| Sodium Chloride and Dextrose Injection IP(0.9% W/V and 5% W/v) | (N)251074Mfg 2025-04 · Exp 2027-03 | Klokter Lifesciences Pvt.Ltd Samora | The sample does not conform to I.P w.r.t Sterility TestSterility | DTL, Dalgate Srinagar Kashmir (J & K)State lab | Feb 2026 |
| Sodium Chloride and Dextrose Injection IP(0.9% W/V and 5% W/v) | (N)251074Mfg 2025-04 · Exp 2027-03 | Klokter Lifesciences Pvt.Ltd Samora | The sample does not conform to I.P w.r.t Sterility TestSterility | DTL, Dalgate Srinagar Kashmir ( J and K)State lab | Jan 2026 |
| Bupivacaine Hydrochloride in Dextrose Injection USP | BD24D2Mfg 2024-12 · Exp 2026-11 | Arco Lifesciences (I) Pvt. LtdMaharashtra | The sample does not conform to U.S.P. with respect to test for Visible Particulates In Injection and Description.Description | CDL, KolkataCDSCO lab | Jan 2026 |
| Bupivacaine Hydrochloride in Dextrose Injection USP (Bupivacaine Heavy) | I-1468Mfg 2024-05 · Exp 2026-04 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample does not conform to U.S.P. with respect to Assay of Dextrose.Assay | CDL, KolkataCDSCO lab | Oct 2025 |
| Multiple Electrolytes And Dextrose Injection Type I IP, | P4BY04Mfg 2025-02 · Exp 2028-01 | Swaroop Pharmaceuticals Pvt. Ltd. A-10Uttar Pradesh | sample received does not conform to I.P. 2022 with respect to the test for Assay of magnesium and phosphateAssay | CDTL, MumbaiCDSCO lab | Sep 2025 |
| Sodium Chloride & Dextrose Injection I.P.( 0.9% W/V Sodium chloride & 5% W/V Dextrose Injection IP) (DNS) | ODF240254Mfg 2024-02 · Exp 2026-01 | Haseeb Pharmaceuticals Pvt. LtdMaharashtra | Assay of DextroseAssay | CDL, KolkataCDSCO lab | Aug 2025 |
| Bupivacaine Hydrochloride In Dextrose Injection USP 4ml | 17B24002Mfg 2024-03 · Exp 2026-02 | Radiant Parenterals Ltd. 242/5 & 6Gujarat | "Determination of volume of Injection in containers".Other | CDL, KolkataCDSCO lab | Jul 2025 |
| Dextrose Injection I.P 5% w/v (D5) | 04BF0660Mfg 2023-09 · Exp 2026-08 | Paschim Banga Pharmaceuticals | SterilitySterility | State Lab KarnatakaState lab | Jun 2025 |
| 0.45 % w/v Sodium Chloride and 5 % w/v Dextrose Injection I.P. (0.45 % DNS), 500 ml | S3BX05Mfg 2024-11 · Exp 2026-10 | Swaroop Pharmaceuticals Pvt. Ltd | Test for SterilitySterility | CDTL MumbaiCDSCO lab | Jun 2025 |
| MULTIPLE ELECTROLYTES AND DEXTROSE INJ. TYPE-1 I.P. (AROLYTE P) | 1227421SMfg 2024-12 · Exp 2027-11 | Shree KrishnaKeshav Laboratories LtdGujarat | Assay of PotassiumAssay | CDTL-MumbaiCDSCO lab | May 2025 |
| Bupivacaine Hydrochloride in Dextrose Injection USP 4 ml | 17B24005Mfg 2024-09 · Exp 2026-08 | Radiant Parenterals LtdGujarat | pH, Bacterial Endotoxins Test, Particulate Matter in Injections and DescriptionDescription | CDL, KolkataCDSCO lab | May 2025 |
| Bupivacaine Hydrochloride In Dextrose Injection USP | AA4009Mfg 2024-03 · Exp 2026-02 | Aishwarya HealthcareSikkim | Particulate matter (visible) and DescriptionDescription | CDL, KolkataCDSCO lab | Mar 2025 |
| Bupivaaine Hydrochloride in Dextrose Injection USP | HIBU23010Mfg 2023-09 · Exp 2025-08 | Health Biotech LtdHimachal Pradesh | Particulate Matter in Injection and DescriptionDescription | CDL KolkataCDSCO lab | Feb 2025 |
Showing 15 of 32 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.